Skip to main content

Table 7 The comparison of clinicopathological characteristics between p16INK4a/Ki-67/ p53 positive and negative RCC patients (n = 118)

From: Epstein–Barr virus infection is associated with the nuclear factor-kappa B p65 signaling pathway in renal cell carcinoma

Variable

p53 Pos

N (%)

p53

Neg

N (%)

p value

P16

Pos

N (%)

P16

Neg

N (%)

p value

Ki-67 Pos

N (%)

Ki-67 Neg

N (%)

p value

High cyto-

NF-κB

N (%)

Low cyto-

NF-κB

N (%)

p value

High nuclear

NF-κB

N (%)

Low nuclear

NF-κB

N (%)

p value

Total

11 (9.3)

107 (90.7)

 

24 (20.3)

94 (79.7)

 

24 (20.3)

94 (79.7)

 

98 (83.0)

20 (16.9)

 

70 (59.3)

48 (40.7)

 

Gender

 Male

7 (63.6)

61 (57)

0.757

17 (70.8)

51 (54.3)

0.169

18 (75)

50 (53.2)

0.065

56 (57.1)

12 (60.0)

> 0.999

38 (54.3)

30 (62.5)

0.449

 Female

4 (36.4)

46 (43)

 

7 (29.1)

43 (45.7)

 

6 (25)

44 (46.8)

 

42 (42.9)

8 (40.0)

 

32 (45.7)

18 (37.5)

 

Age

 ≥ 54

6 (54.5)

57 (53.3)

> 0.999

10 (41.6)

53 (56.4)

0.253

15 (62.5)

48 (51.1)

0.364

52 (53.1)

11 (55)

> 0.999

42 (60)

21 (43.7)

0.094

 ˂ 54

5 (45.5)

50 (46.7)

 

14 (58.3)

41 (43.6)

 

9 (37.5)

46 (48.9)

 

46 (46.9)

9 (45)

 

28 (40)

27 (56.2)

 

Tumor location

 Right

7 (63.6)

58 (54.2)

0.752

14 (58.3)

51 (54.3)

0.819

11 (45.8)

54 (57.4)

0.361

56 (57.1)

9 (45.0)

0.336

36 (51.4)

29 (60.4)

0.353

 Left

4 (36.4)

49 (45.8)

 

10 (41.6)

43 (45.7)

 

13 (54.2)

40 (42.6)

 

42 (42.9)

11 (55.0)

 

34 (48.6)

19 (39.6)

 

Tumor grade

 G1

3 (27.2)

50 (46.7)

0.006

9 (37.5)

44 (46.8)

0.280

3 (12.5)

50 (53.2)

< 0.0001

36 (36.7)

17 (85.0)

0.003

30 (42.9)

23 (47.9)

0.485

 G2

2 (18.1)

40 (37.3)

 

8 (33.3)

34 (36.1)

 

7 (29.2)

35 (37.2)

 

39 (39.8)

3 (15.0)

 

23 (32.8)

19 (39.6)

 

 G3

6 (54.5)

14 (13.1)

 

7 (29.1)

13 (13.8)

 

13 (54.2)

7 (7.4)

 

20 (20.4)

0

 

15 (21.4)

5 (10.4)

 

 G4

0

3 (2.8)

 

0

3 (3.2)

 

1 (4.1)

2 (2.1)

 

3 (3.1)

0

 

2 (2.9)

1 (2.1)

 

 G1 + G2

5 (45.5)

90 (84.1)

0.007

17 (70.8)

78 (82.9)

0.246

10 (41.7)

85 (90.4)

< 0.0001

75 (76.5)

20 (100)

0.012

53 (75.7)

42 (87.5)

0.156

 G3 + G4

6 (54.5)

17 (15.9)

 

7 (29.1)

16 (17.0)

 

14 (58.3)

9 (9.6)

 

23 (23.50

0

 

17 (24.3)

6 (12.5)

 

pT category

 pT1

6 (54.5)

49 (45.8)

0.014

11 (45.8)

44 (46.8)

0.209

8 (33.3)

47 (50)

0.0002

42 (42.8)

13 (65)

0.254

31 (44.3)

24 (50)

0.364

 pT2

3 (27.2)

40 (37.3)

 

6 (25.0)

37 (39.4)

 

5 (20.8)

38 (40.4)

 

37 (37.7)

6 (30)

 

29 (41.4)

14 (29.2)

 

pT3

1 (9.1)

18 (16.8)

 

7 (29.1)

12 (12.7)

 

10 (41.7)

9 (9.6)

 

18 (18.4)

1 (5)

 

10 (14.3)

9 (18.7)

 

 pT4

1 (9.1)

0

 

0

1 (1.1)

 

1 (4.2)

0

 

1 (1.0)

0

 

0

1 (2.1)

 

 pT1 + pT2

9 (81.9)

89 (83.2)

> 0.999

17 (70.8)

81 (86.1)

0.122

13 (54.2)

85 (90.4)

0.0001

79 (80.6)

19 (95)

0.190

60 (85.7)

38 (79.2)

0.351

 pT3 + pT4

2 (18.1)

18 (16.8)

 

7 (29.1)

13 (13.8)

 

11 (45.8)

9 (9.6)

 

19 (19.4)

1 (5)

 

10 (14.3)

10 (20.8)

 

Histologic types

 Conventional

3 (27.3)

70 (65.4)

0.020 a

12 (50)

61 (64.9)

0.239

12 (50)

61 (64.9)

0.239 a

61 (62.2)

12 (60)

0.850

41 (58.6)

32 (66.6)

0.373

 Nonconventional

8 (72.7)

37 (34.6)

 

12 (50)

33 (35.1)

 

12 (50)

33 (35.1)

 

37 (37.7)

8 (40)

 

29 (41.4)

16 (33.3)

 

 Papillary

6 (54.5)

20 (18.7)

 

9 (37.5)

17 (18.1)

 

8 (33.3)

18 (19.1)

 

23 (23.4)

3 (15)

 

20 (28.6)

6 (12.5)

 

 Chromophobe

1 (9.1)

13 (12.1)

 

1 (4.1)

13 (13.8)

 

0

14 (14.9)

 

9 (9.2)

5 (25)

 

5 (7.1)

9 (18.7)

 

 Collecting duct

0

1 (0.9)

 

0

1 (1.1)

 

1 (4.2)

0

 

1 (1.0)

0

 

1 (1.4)

0

 

 Unclassified

1 (9.1)

3 (2.8)

 

2 (8.3)

2 (2.1)

 

3 (12.5)

1 (1.1)

 

4 (4.1)

0

 

3 (4.3)

1 (2.1)

 

EBV

 Positive

5 (45.4)

28 (26.2)

0.287

8 (33.3)

25 (26.6)

0.611

8 (33.3)

25 (26.6)

0.611

31 (31.6)

2 (10)

0.058

29 (41.4)

4 (8.3)

< 0.0001

 Negative

6 (54.5)

79 (73.8)

 

16 (66.6)

69 (73.4)

 

16 (66.6)

69 (73.6)

 

67 (68.4)

18 (90)

 

41 (58.6)

44 (91.7)

 
  1. Pos positive, Neg negative, Cyto cytoplasmic, P16 p16INK4a, pT primary tumor